Skip to main content
NASDAQ:EBACU

European Biotech Acquisition Competitors

$10.05
+0.05 (+0.50 %)
(As of 05/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.01
$10.05
50-Day Range
$9.80
$10.15
52-Week Range
$9.77
$10.49
Volume677 shs
Average Volume87,560 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

European Biotech Acquisition (NASDAQ:EBACU) Vs. AFAQU, ANEB, ANZUU, ATSPU, ARRWU, and AUUD

Should you be buying EBACU stock or one of its competitors? Companies in the industry of "--" are considered alternatives and competitors to European Biotech Acquisition, including AF Acquisition (AFAQU), Anebulo Pharmaceuticals (ANEB), Anzu Special Acquisition Corp I (ANZUU), Archimedes Tech SPAC Partners (ATSPU), Arrowroot Acquisition (ARRWU), and Auddia (AUUD).

European Biotech Acquisition (NASDAQ:EBACU) and AF Acquisition (NASDAQ:AFAQU) are both -- companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership and valuation.

Earnings & Valuation

This table compares European Biotech Acquisition and AF Acquisition's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
European Biotech AcquisitionN/AN/AN/AN/AN/A
AF AcquisitionN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for European Biotech Acquisition and AF Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
European Biotech Acquisition0000N/A
AF Acquisition0000N/A

Profitability

This table compares European Biotech Acquisition and AF Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
European Biotech AcquisitionN/AN/AN/A
AF AcquisitionN/AN/AN/A

European Biotech Acquisition (NASDAQ:EBACU) and Anebulo Pharmaceuticals (NASDAQ:ANEB) are both -- companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership and valuation.

Earnings & Valuation

This table compares European Biotech Acquisition and Anebulo Pharmaceuticals' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
European Biotech AcquisitionN/AN/AN/AN/AN/A
Anebulo PharmaceuticalsN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for European Biotech Acquisition and Anebulo Pharmaceuticals, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
European Biotech Acquisition0000N/A
Anebulo Pharmaceuticals0000N/A

Profitability

This table compares European Biotech Acquisition and Anebulo Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
European Biotech AcquisitionN/AN/AN/A
Anebulo PharmaceuticalsN/AN/AN/A

European Biotech Acquisition (NASDAQ:EBACU) and Anzu Special Acquisition Corp I (NASDAQ:ANZUU) are both -- companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership and valuation.

Earnings & Valuation

This table compares European Biotech Acquisition and Anzu Special Acquisition Corp I's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
European Biotech AcquisitionN/AN/AN/AN/AN/A
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for European Biotech Acquisition and Anzu Special Acquisition Corp I, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
European Biotech Acquisition0000N/A
Anzu Special Acquisition Corp I0000N/A

Profitability

This table compares European Biotech Acquisition and Anzu Special Acquisition Corp I's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
European Biotech AcquisitionN/AN/AN/A
Anzu Special Acquisition Corp IN/AN/AN/A

European Biotech Acquisition (NASDAQ:EBACU) and Archimedes Tech SPAC Partners (NASDAQ:ATSPU) are both -- companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership and valuation.

Earnings & Valuation

This table compares European Biotech Acquisition and Archimedes Tech SPAC Partners' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
European Biotech AcquisitionN/AN/AN/AN/AN/A
Archimedes Tech SPAC PartnersN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for European Biotech Acquisition and Archimedes Tech SPAC Partners, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
European Biotech Acquisition0000N/A
Archimedes Tech SPAC Partners0000N/A

Profitability

This table compares European Biotech Acquisition and Archimedes Tech SPAC Partners' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
European Biotech AcquisitionN/AN/AN/A
Archimedes Tech SPAC PartnersN/AN/AN/A

European Biotech Acquisition (NASDAQ:EBACU) and Arrowroot Acquisition (NASDAQ:ARRWU) are both -- companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership and valuation.

Earnings & Valuation

This table compares European Biotech Acquisition and Arrowroot Acquisition's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
European Biotech AcquisitionN/AN/AN/AN/AN/A
Arrowroot AcquisitionN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for European Biotech Acquisition and Arrowroot Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
European Biotech Acquisition0000N/A
Arrowroot Acquisition0000N/A

Profitability

This table compares European Biotech Acquisition and Arrowroot Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
European Biotech AcquisitionN/AN/AN/A
Arrowroot AcquisitionN/AN/AN/A

European Biotech Acquisition (NASDAQ:EBACU) and Auddia (NASDAQ:AUUD) are both -- companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership and valuation.

Profitability

This table compares European Biotech Acquisition and Auddia's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
European Biotech AcquisitionN/AN/AN/A
AuddiaN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for European Biotech Acquisition and Auddia, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
European Biotech Acquisition0000N/A
Auddia0000N/A

Earnings & Valuation

This table compares European Biotech Acquisition and Auddia's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
European Biotech AcquisitionN/AN/AN/AN/AN/A
AuddiaN/AN/AN/AN/AN/A


European Biotech Acquisition Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
AFAQU
AF Acquisition
0.0$10.00+0.1%$0.00N/A0.00
ANEB
Anebulo Pharmaceuticals
0.0$7.00+1.1%$0.00N/A0.00
ANZUU
Anzu Special Acquisition Corp I
0.0$10.00+0.4%$0.00N/A0.00
ATSPU
Archimedes Tech SPAC Partners
0.0$10.00+0.0%$0.00N/A0.00
ARRWU
Arrowroot Acquisition
0.0$10.00+0.2%$0.00N/A0.00
AUUD
Auddia
0.0$2.40+4.2%$0.00N/A0.00
BRIVU
B. Riley Principal 250 Merger Corp. Units
0.0$10.00+0.1%$0.00N/A0.00
BSA
BrightSphere Investment Group
0.0$25.13+0.2%$0.00N/A0.00
CPZ
Calamos Long/Short Equity & Dynamic Income Term Trust
0.0$20.30+0.8%$0.00N/A0.00
CMLTU
CM Life Sciences III
0.0$10.69+1.1%$0.00N/A0.00Quiet Period Expiration
CRZNU
Corazon Capital V838 Monoceros
0.0$10.00+0.0%$0.00N/A0.00
DKDCU
Data Knights Acquisition Corp. Unit
0.0$10.09+0.0%$0.00N/A0.00
DCRCU
Decarbonization Plus Acquisition Corp III
0.0$10.00+0.2%$0.00N/A0.00
DLY
DoubleLine Yield Opportunities Fund
0.0$19.68+0.1%$0.00N/A0.00
EVOJ
Evo Acquisition
0.3$9.77+0.0%$0.00N/A0.00
FRSGU
First Reserve Sustainable Growth
0.0$9.99+0.0%$0.00N/A0.00
FMIVU
Forum Merger IV
0.0$9.96+0.1%$0.00N/A0.00News Coverage
FRONU
Frontier Acquisition
0.0$10.05+0.4%$0.00N/A0.00
HERAU
FTAC Hera Acquisition
0.0$10.00+0.0%$0.00N/A0.00High Trading Volume
GLHAU
Glass Houses Acquisition
0.0$9.97+0.3%$0.00N/A0.00News Coverage
GLSPU
Global SPAC Partners
0.0$9.98+0.1%$0.00N/A0.00News Coverage
GMLPP
Golar LNG Partners LP 8.75% CUM PFD A
0.8$23.09+0.0%$0.00N/A0.00High Trading Volume
GAMCU
Golden Arrow Merger
0.0$9.93+0.1%$0.00N/A0.00
GBRGU
Goldenbridge Acquisition
0.0$10.45+0.0%$0.00N/A0.00
GSEVU
Gores Holdings VII
0.0$10.01+0.1%$0.00N/A0.00
HGLB
Highland Global Allocation Fund
0.3$8.56+1.6%$0.00N/A0.00
IPVIU
InterPrivate IV InfraTech Partners
0.0$9.97+0.0%$0.00N/A0.00
ISLEU
Isleworth Healthcare Acquisition
0.0$9.90+0.0%$0.00N/A0.00
KSICU
Kadem Sustainable Impact
0.0$9.99+0.2%$0.00N/A0.00News Coverage
LCAAU
L Catterton Asia Acquisition
0.0$10.06+0.0%$0.00N/A0.00
LEGAU
Lead Edge Growth Opportunities
0.0$9.96+0.1%$0.00N/A0.00
LVRAU
Levere
0.0$10.01+0.0%$0.00N/A0.00
LEV
Lion Electric
1.0$15.78+9.7%$0.00N/A0.00Analyst Report
News Coverage
Gap Down
MHNC
Maiden Holdings North America
0.8$23.94+0.1%$0.00N/A0.00
MAQCU
Maquia Capital Acquisition Co. Unit
0.0$9.98+0.1%$0.00N/A0.00
NMCO
Nuveen Municipal Credit Opportunities Fund
0.0$14.88+0.6%$0.00N/A0.00
PIMCO Energy and Tactical Credit Opportunities Fund logo
NRGX
PIMCO Energy and Tactical Credit Opportunities Fund
0.8$11.11+0.0%$0.00N/A0.00Insider Buying
PYT
PPLUS Trust Series GSC-2 GSC 2 CT FL RT
0.4$24.00+0.0%$0.00N/A0.00
FRWAU
PWP Forward Acquisition Corp. I
0.0$10.00+0.0%$0.00N/A0.00
RTPYU
Reinvent Technology Partners Y
0.0$10.08+0.1%$0.00N/A0.00
RXRAU
RXR Acquisition
0.0$9.99+0.1%$0.00N/A0.00
SPKBU
Silver Spike Acquisition Corp II
0.0$9.99+0.0%$0.00N/A0.00
SBEAU
SilverBox Engaged Merger Corp I
0.0$10.00+0.0%$0.00N/A0.00
SRNGU
Soaring Eagle Acquisition
0.0$10.26+0.0%$0.00N/A0.00News Coverage
TALS
Talaris Therapeutics
0.3$13.05+8.6%$0.00N/A0.00Insider Buying
News Coverage
TBSAU
TB SA Acquisition
0.0$9.95+0.0%$0.00N/A0.00News Coverage
TCVA
TCV Acquisition
0.0$10.15+0.4%$0.00N/A0.00
TEAF
Tortoise Essential Assets Income Term Fund
1.2$14.24+1.9%$0.00N/A0.00Dividend Announcement
News Coverage
TravelCenters of America LLC 8% SR NT 2030 logo
TANNZ
TravelCenters of America LLC 8% SR NT 2030
0.7$25.68+0.2%$0.00N/A0.00High Trading Volume
TravelCenters of America LLC SR NT logo
TANNL
TravelCenters of America LLC SR NT
0.5$26.09+0.2%$0.00N/A0.00
This page was last updated on 5/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.